...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis
【24h】

First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis

机译:一种新型自膨胀型超环形转座心瓣的首先植入用于经截面主动脉瓣植入的小型退化主动脉外科生物假体

获取原文
获取原文并翻译 | 示例

摘要

With next-generation valves such as the ALLEGRA valve from NewValve Technologies (NVT), Hechingen Germany, there is a very likely treatment expansion for patients with aortic valve disease. Besides treatment of native valvular aortic stenosis with the ALLEGRA valve, the special implant mechanism seems to be an appealing concept for patients with degenerated surgical bioprostheses. We report the first case of a transfemoral implantation in small degenerated surgical bioprosthesis of a 76-year-old woman.
机译:利用来自NewValve Technologies(NVT)的Allegra Valve等下一代阀门,Hechingen德国,对主动脉瓣病的患者有很可能的治疗扩张。 除了用Allegra Valve治疗天然瓣膜主动脉狭窄,特殊植入机制似乎是退化外科生物保护型患者的吸引力概念。 我们报告了一个76岁女性小退化外科生物假期中的常熔植入的案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号